Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors

Carcinogenesis

Volumn 20, Issue 9, 1999, Pages 1819-1823

  Salnikow, Konstantin ^b   An, Won G ^a   Melillo, Giovanni ^a   Blagosklonny, Mikhail V ^a   Costa, Max ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; HYPOXIA INDUCIBLE FACTOR; MUTANT PROTEIN; NICKEL; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

3T3 CELLS; ADENOCARCINOMA; ANIMALS; BONE NEOPLASMS; BREAST NEOPLASMS; BRONCHI; CADMIUM CHLORIDE; CARCINOGENS, ENVIRONMENTAL; CELL HYPOXIA; CELL TRANSFORMATION, NEOPLASTIC; COBALT; CRICETINAE; CRICETULUS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, P53; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MICE; NEOPLASM PROTEINS; NICKEL; NUCLEAR PROTEINS; OSTEOSARCOMA; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032877460     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.9.1819     Document Type: Article

References (45)

1. Ottolenghi, A.D., Haseman, J.K., Payne, W.W., Falk, H.L. and MacFarland, H.N. (1975) Inhalation studies of nickel sulfide in pulmonary carcinogenesis of rats. J. Natl Cancer Inst., 54, 1165-1172.
2. Sunderman, F.W.Jr (1981) Recent research on nickel carcinogenesis. Environ. Health Perspect., 40, 131-141.
3. Costa, M. (1991) Molecular mechanisms of nickel carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 31, 321-327.
4. Oller, A.R., Costa, M. and Oberdörster, G. (1997) Carcinogenicity assessment of selected nickel compounds, Toxicol. Appl. Pharmacol., 143, 152-166.
5. Dunnick, J.K., Elwell, M.R., Radovsky, A.E., Benson, J.M., Hahn, F.F., Nikula, K.J., Barr, E.B. and Hobbs, C.H. (1995) Comparative carcinogenic effects of nickel subsulfide, nickel oxide, or nickel sulfate hexahydrate chronic exposures in the lung. Cancer Res., 55, 5251-5256.
6. Biedermann, K.A. and Landolph, J.R. (1987) Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res., 47, 3815-3823.
7. Conway, K. and Costa, M. (1989) Nonrandom chromosomal alterations in nickel-transformed Chinese hamster embryo cells. Cancer Res., 49, 6032-6038.
8. Trott, D.A., Cuthbert, A.P., Overell, R.W., Russo, I. and Newbold, N.F. (1995) Mechanisms involved in the immortalization of mammalian cells by ionizing radiation and chemical carcinogens. Carcinogenesis, 16, 193-204.
9. Rani, A.S., Qu, D.-Q., Sidhu, M.K., Panagakos, F., Shah, V., Klein, K.M., Brown, N., Pathak, S. and Kumar, S. (1993) Transformation of immortal, non-turaorigenic osteoblast-like human osteosarcoma cells to the tumorigenic phenotype by nickel sulfate. Carcinogenesis, 14, 947-953.
10. Lin, X., Dowjat, K. and Costa, M. (1994) Nickel-induced transformation of human cells causes loss of the phosphorylation of the retinoblastoma protein. Cancer Res., 54, 2751-2754.
11. Miller, A.C., Blakely, W.F., Livengood, D. et al. (1998) Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uraniumuranyl chloride. Environ. Health Perspect., 106, 465-471.
12. 2+ compounds. Cancer Res., 58, 2182-2189.
13. Fletcher, G.G., Rosetto, F.E., Turnbull, J.D. and Nieboer, E. (1994) Toxicity, uptake and mutagenicity of particulate and soluble nickel compounds. Environ. Health Perspect., 102 (suppl. 3), 69-79.
14. Salnikow, K., Cosentino, S., Klein, C. and Costa, M. (1994) Loss of thrombospondin transcriptional activity in nickel-transformed cells. Mol. Cell. Biol., 14, 851-858.
15. Salnikow, K., Wang, S. and Costa, M. (1997) Induction of activating transcription factor I by nickel and its role as a negative regulator of thrombospondin I gene expression. Cancer Res., 57, 5060-5066.
16. Graven, K.K., McDonald, R.J. and Farber, H.W. (1998) Hypoxic regulation of endothelial glyceraldehyde-3-phosphate dehydrogenase. Am. J. Physiol., 43, 347-355.
17. Namiki, A., Brogi, E., Kearney, M., Kim, E.A., Wu, T., Coffinhal, T., Varticovski, L. and Isner, J.M. (1995) Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem., 270, 31189-31195.
18. Huang, L.E., Ho, V., Arany, Z., Krainc, C., Galson, D., Tendler, D., Livingston, D.M. and Bunn, H.F. (1997) Erythropoietin gene regulation depends on heme-dependent oxygen sensing and assembly of interacting transcription factors. Kidney Int., 51, 548-553.
19. Salceda, S. and Caro, J. (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redoxinduced changes. J. Biol. Chem., 272, 22642-22647.
20. 2 tension. Proc. Natl Acad. Sci. USA, 92, 5510-5514.
21. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D. and Semenza, G.L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16, 4604-4613.
22. Maxwell, P.H., Dachs, G.U., Gleadle, J.M., Nicholls, L.G., Harris, A.L., Stratford, I.J., Hankinson, O., Pugh, C.W. and Ratcliffe, P.J. (1997) Hypoxiainducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA, 94, 8104-8109.
23. Graeber, T.G., Peterson, J.F., Tsai, M., Monica, K., Fornace, A.J.Jr and Giaccia, A.J. (1994) Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol., 14, 6264-6277.
24. Graeber, T.G., Osmanian, C., Jacks, T., Houseman, D.E., Koch, C.J., Lowe, S.W. and Giaccia, A.J. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature, 379, 88-91.
25. An, W.G., Kanekal, M., Simon, M.C., Mallepe, E., Blagosklonny, M.V. and Neckers, L.M. (1998) Stabilization of wild-type p53 by hypoxia-inducible factor 1a. Nature, 392, 405-408.
26. Ko, L.J. and Prives, C. (1996) p53: puzzle and paradigm. Genes Dev., 10, 1054-1072.
27. Wang, X.-W. and Harris, C.C. (1997) p53 tumor-suppressor gene: clues to molecular carcinogenesis. J. Cell Physiol., 173, 247-255.
28. Blagosklonny, M.V. (1997) Loss of function and p53 stabilization. Oncogene, 15, 1889-1893.
29. Maehle, L., Metcalf, R.A., Ryberg, D., Bennett, W.P., Harris, C.C. and Haugen, A. (1992) Altered p53 gene structure and expression in human epithelial cells after exposure to nickel. Cancer. Res., 52, 218-221.
30. Romano, J.W., Ehrhart, J.C., Duthu, A., Kim, C.M., Appella, E. and May, P. (1989) Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line. Oncogene, 4, 1483-1488.
31. Wang, X.-W., Imbra, R.J. and Costa, M. (1988) Characterization of mouse cell lines resistant to nickel(II) ions. Cancer Res., 48, 6850-6854.
32. Blagosklonny, M.V. and El-Deiry, W.S. (1996) In-vitro evaluation of p53-expressing adenovirus as an anti-cancer drug. Int. J. Cancer, 67, 386-392.
33. An, W.G., Chuman, Y., Fojo, T. and Blagosklonny, M.V. (1998) Inhibitors of transcription, proteasome inhibitors and DNA-damaging drugs differentially affect feedback of p53 degradation. Exp. Cell Res., 244, 54-60.
34. Doll, R., Morgan, L.G. and Speizer, F.E. (1970) Cancers of the lung and nasal sinuses in nickel workers. Br. J. Cancer, 24, 623-632.
35. Langard, S. (1994) Nickel-related cancer in welders. Sci. Total Environ., 148, 303-309.
36. Ward, J.J., Thornbury, D.D., Lemons, J.E. and Dunham, W.K. (1990) Metalinduced sarcoma: a case report and literature review. Clin. Orthop., 252, 299-306.
37. Goldberg, M.A., Dunning, S.P. and Bunn, H.F. (1988) Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science, 242, 1412-1415.
38. Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H. and Tsujimoto, Y. (1995) Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xl. Nature, 374, 811-813.
39. Yao, K.-S., Clayton, M. and O'Dwyer, P.J. (1995) Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J. Natl Cancer Inst., 87, 117-122.
40. Carmeliet, P., Dor, Y., Herbert, J.-M. et al. (1998) Role of HIF-1a in hypoxiamediated apoptosis, cell proliferation and tumor angiogenesis. Nature, 394, 485-490.
41. Blagosklonny, M.V., An, W.G., Romanova, L.Y., Trepel, J., Fojo, T. and Neckers, L.M. (1998) p53 inhibits hypoxia-inducible factor-stimulated transcription. J. Biol. Chem., 273, 11995-11998.
42. Schedle, A., Samorapoompichit, P., Rausch-Fan, X.H. et al. (1995) Response of L-929 fibroblasts, human gingival fibroblasts and human tissue mast cells to various metal cations. J. Dent. Res., 74, 1513-1520.
43. Shiao, Y.-H., Lee, S.-H. and Kasprzak, K. (1998) Cell cycle arrest, apoptosis and p53 expression in nickel(II) acetate-treated Chinese hamster ovary cells. Carcinogenesis, 19, 1203-1207.
44. Lee, H., Lamer, J.M. and Hamlin, J.L. (1997) Cloning and characterization of Chinese hamster p53 cDNA. Gene, 184, 177-183.
45. Hu, T. and Aardema, M.J. (1999) Characterization of p53 protein in Chinese hamster cell lines: CHO-K1, CHO-WBL and CHL. Environ. Mol. Mutagen., 33 (suppl. 30), 33.